الولايات المتحدة · منصات وبيانات · MarketBeat

BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at Wells Fargo & Company

نشره MarketBeat · الولايات المتحدة منذ 1 س

Wells Fargo & Company decreased their price objective on BioNTech from $140.00 to $125.00 and set an "overweight" rating for the company in a report on Wednesday.

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

The Motley Fool

AI Regulation Was on the Ballot In These States. Here Are The Elon Musk Stocks That Could Be Impacted.

Seeking Alpha

IREN Q1 earnings on deck: what to expect

MarketWatch

Depressing, but true: If you want to get ahead at work, embrace virtue signaling

CNBC

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Investing.com